USAID negotiating Depo purchase, but shelf life proves problematic.
D000569:Americas; D003132:Commerce; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D019049:Developed Countries; D004467:Economics; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D006077:Government Agencies; D006297:Health Services Accessibility; D007267:Injections; D007390:International Agencies; D017258:Medroxyprogesterone Acetate; D009656:North America; D009938:Organizations; D014480:United Nations; D014481:United States
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate
Americas; Commerce; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Availability; Contraceptive Methods; Critique; Depo-provera; Developed Countries; Economic Factors; Family Planning; Government Agencies; Injectables; International Agencies; Macroeconomic Factors; Medroxyprogesterone Acetate; North America; Northern America; Organizations; Prices; Un; Unfpa; United States; Usaid